144 related articles for article (PubMed ID: 28618769)
21. Cytotoxic T-lymphocyte antigen-4 +49A/G polymorphisms in Sudanese adults with type 1 diabetes and latent autoimmune diabetes.
Alshareef SA; Omar SM; Hamdan HZ; Adam I
BMC Res Notes; 2019 Nov; 12(1):769. PubMed ID: 31771625
[TBL] [Abstract][Full Text] [Related]
22. CTLA-4 (+49A/G) polymorphism and type-1 diabetes in Turkish children.
Çelmeli F; Türkkahraman D; Özel D; Akçurin S; Yegin O
J Clin Res Pediatr Endocrinol; 2013; 5(1):40-3. PubMed ID: 23367498
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms of the angiotensin converting enzyme gene in Iranian Azeri Turkish women with unexplained recurrent pregnancy loss.
Bagheri M; Abdi Rad I; Omrani MD; Nanbaksh F
Hum Fertil (Camb); 2010; 13(2):79-82. PubMed ID: 20722577
[TBL] [Abstract][Full Text] [Related]
24. Determination of VEGFR-2 (KDR) -604A>G polymorphism in recurrent pregnancy loss.
Boldeanu L; Siloşi CA; Pădureanu V; Dijmărescu AL; Manolea MM; Tabacu MC; Boldeanu MV; Popescu-Drigă MV; Poenariu IS; Pădureanu R; Novac LV; Novac MB
Rom J Morphol Embryol; 2018; 59(4):1053-1059. PubMed ID: 30845284
[TBL] [Abstract][Full Text] [Related]
25. CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese.
Qi P; Ruan CP; Wang H; Zhou FG; Xu XY; Gu X; Zhao YP; Dou TH; Gao CF
Int J Colorectal Dis; 2010 Jan; 25(1):39-45. PubMed ID: 19787358
[TBL] [Abstract][Full Text] [Related]
26. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease.
Sallakci N; Bacanli A; Coskun M; Yavuzer U; Alpsoy E; Yegin O
Clin Exp Dermatol; 2005 Sep; 30(5):546-50. PubMed ID: 16045690
[TBL] [Abstract][Full Text] [Related]
27. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of association between the +49A/G polymorphism of cytotoxic T-lymphocyte antigen-4 and thyroid associated ophthalmopathy.
Wang H; Zhu LS; Cheng JW; Cai JP; Li Y; Ma XY; Wei RL
Curr Eye Res; 2015; 40(12):1195-203. PubMed ID: 25615025
[TBL] [Abstract][Full Text] [Related]
29. Association of Cytotoxic T Lymphocyte Antigen-4 Gene Polymorphisms with Psoriasis Vulgaris: A Case-Control Study in Turkish Population.
Dursun HG; Yılmaz HO; Dursun R; Kulaksızoğlu S
J Immunol Res; 2018; 2018():1643906. PubMed ID: 29850619
[TBL] [Abstract][Full Text] [Related]
30. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.
Liang J; Zhang S; Luo Q; Li W; Tian X; Zhang F; Zhao T; Chen X; Zhang X
Gene; 2015 Sep; 568(2):196-202. PubMed ID: 26013045
[TBL] [Abstract][Full Text] [Related]
31. IL-6 gene promoter polymorphisms: genetic susceptibility to recurrent pregnancy loss.
Demirturk F; Ates O; Gunal O; Bozkurt N; Aysal T; Nacar MC
Bratisl Lek Listy; 2014; 115(8):479-82. PubMed ID: 25246282
[TBL] [Abstract][Full Text] [Related]
32. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
[TBL] [Abstract][Full Text] [Related]
33. Association between CTLA-4 gene polymorphism and ankylosing spondylitis: a case-control study.
Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
Int J Clin Exp Pathol; 2015; 8(6):7421-5. PubMed ID: 26261646
[TBL] [Abstract][Full Text] [Related]
34. Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.
Geng R; Song F; Yang X; Sun P; Hu J; Zhu C; Zhu B; Fan W
Tumour Biol; 2014 Apr; 35(4):3627-39. PubMed ID: 24307627
[TBL] [Abstract][Full Text] [Related]
35. Association of CTLA-4 (+49A/G) gene polymorphism with type 1 diabetes mellitus in Egyptian children.
Mosaad YM; Elsharkawy AA; El-Deek BS
Immunol Invest; 2012; 41(1):28-37. PubMed ID: 21615267
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of CTLA-4 (+ 49A/G) polymorphism association with rheumatoid arthritis in Egyptian patients.
Ragab D; Hammoda RM; El-Gharbawy NH; Salem R
Egypt J Immunol; 2023 Jul; 30(3):180-189. PubMed ID: 37440667
[TBL] [Abstract][Full Text] [Related]
37. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome.
Gottenberg JE; Loiseau P; Azarian M; Chen C; Cagnard N; Hachulla E; Puechal X; Sibilia J; Charron D; Mariette X; Miceli-Richard C
Arthritis Res Ther; 2007; 9(2):R24. PubMed ID: 17341301
[TBL] [Abstract][Full Text] [Related]
38. Association between the cytotoxic T-lymphocyte antigen 4 +49A/G polymorphism and bladder cancer risk.
Wang L; Su G; Zhao X; Cai Y; Cai X; Zhang J; Liu J; Wang T; Wang J
Tumour Biol; 2014 Feb; 35(2):1139-42. PubMed ID: 24014088
[TBL] [Abstract][Full Text] [Related]
39. Association of CTLA-4 and CD28 Gene Polymorphisms with Type 1 Diabetes in South Indian Population.
Gunavathy N; Asirvatham A; Chitra A; Jayalakshmi M
Immunol Invest; 2019 Aug; 48(6):659-671. PubMed ID: 31094250
[TBL] [Abstract][Full Text] [Related]
40. Cytokine gene polymorphisms and susceptibility to recurrent pregnancy loss in Iranian women.
Kamali-Sarvestani E; Zolghadri J; Gharesi-Fard B; Sarvari J
J Reprod Immunol; 2005 Apr; 65(2):171-8. PubMed ID: 15811521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
